For: | Hsueh CT, Selim JH, Tsai JY, Hsueh CT. Nanovectors for anti-cancer drug delivery in the treatment of advanced pancreatic adenocarcinoma. World J Gastroenterol 2016; 22(31): 7080-7090 [PMID: 27610018 DOI: 10.3748/wjg.v22.i31.7080] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i31/7080.htm |
Number | Citing Articles |
1 |
Francesco Petrella, Isabella Rimoldi, Giorgio Facchetti, Lorenzo Spaggiari. Novel platinum agents and mesenchymal stromal cells for thoracic malignancies: state of the art and future perspectives. Expert Opinion on Therapeutic Patents 2018; 28(11): 813 doi: 10.1080/13543776.2018.1528234
|
2 |
Olga Klaudia Szewczyk, Piotr Roszczenko, Robert Czarnomysy, Anna Bielawska, Krzysztof Bielawski. An Overview of the Importance of Transition-Metal Nanoparticles in Cancer Research. International Journal of Molecular Sciences 2022; 23(12): 6688 doi: 10.3390/ijms23126688
|
3 |
Sébastien Dilly, Mélanie Garnier, Marion Solé, Rémi Bailly, Nada Taib, Isabelle Bestel. In Silico Identification of a Key Residue for Substrate Recognition of the Riboflavin Membrane Transporter RFVT3. Journal of Chemical Information and Modeling 2020; 60(3): 1368 doi: 10.1021/acs.jcim.9b01020
|
4 |
Valentina Coccè, Davide Farronato, Anna Teresa Brini, Carla Masia, Aldo Bruno Giannì, Giovanna Piovani, Francesca Sisto, Giulio Alessandri, Francesca Angiero, Augusto Pessina. Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09175-4
|
5 |
Ying Li, Xiu-Liang Cui, Qing-Shan Chen, Jing Yu, Hai Zhang, Jie Gao, Du-Xin Sun, Guo-Qing Zhang. Cationic liposomes induce cytotoxicity in HepG2 via regulation of lipid metabolism based on whole-transcriptome sequencing analysis. BMC Pharmacology and Toxicology 2018; 19(1) doi: 10.1186/s40360-018-0230-5
|
6 |
Sally A. El-Zahaby, Yosra S.R. Elnaggar, Ossama Y. Abdallah. Reviewing two decades of nanomedicine implementations in targeted treatment and diagnosis of pancreatic cancer: An emphasis on state of art. Journal of Controlled Release 2019; 293: 21 doi: 10.1016/j.jconrel.2018.11.013
|
7 |
Francesco Petrella, Valentina Coccè, Carla Masia, Martina Milani, Emanuela Omodeo Salè, Giulio Alessandri, Eugenio Parati, Francesca Sisto, Francesca Pentimalli, Anna T. Brini, Augusto Pessina, Lorenzo Spaggiari. Paclitaxel-releasing mesenchymal stromal cells inhibit in vitro proliferation of human mesothelioma cells. Biomedicine & Pharmacotherapy 2017; 87: 755 doi: 10.1016/j.biopha.2017.01.118
|
8 |
Yvette N. Lamb, Lesley J. Scott. Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma. Drugs 2017; 77(7): 785 doi: 10.1007/s40265-017-0741-1
|
9 |
Hassan Mostoufi, Gholamhossein Yousefi, Ali-mohammad Tamaddon, Omidreza Firuzi. Reversing multi-drug tumor resistance to Paclitaxel by well-defined pH-sensitive amphiphilic polypeptide block copolymers via induction of lysosomal membrane permeabilization. Colloids and Surfaces B: Biointerfaces 2019; 174: 17 doi: 10.1016/j.colsurfb.2018.10.072
|
10 |
Michelle K. Greene, Michael C. Johnston, Christopher J. Scott. Nanomedicine in Pancreatic Cancer: Current Status and Future Opportunities for Overcoming Therapy Resistance. Cancers 2021; 13(24): 6175 doi: 10.3390/cancers13246175
|